I4E

CARMUSTINE

Created:	2024-02-14
Last modified:	2026-06-10

Find Related PDB Entry
1 entries where I4E is found as a standalone ligand

Find related ligands: Help
Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	21
Chiral Atom Count	0
Bond Count	20
Aromatic Bond Count	0

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	CARMUSTINE
Synonyms	1,3-bis(2-chloroethyl)-1-nitroso-urea
Systematic Name (OpenEye OEToolkits)	1,3-bis(2-chloroethyl)-1-nitroso-urea
Formula	C₅ H₉ Cl₂ N₃ O₂
Molecular Weight	214.05
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	CACTVS	3.385	ClCCNC(=O)N(CCCl)N=O
SMILES	OpenEye OEToolkits	2.0.7	C(CCl)NC(=O)N(CCCl)N=O
Canonical SMILES	CACTVS	3.385	ClCCNC(=O)N(CCCl)N=O
Canonical SMILES	OpenEye OEToolkits	2.0.7	C(CCl)NC(=O)N(CCCl)N=O
InChI	InChI	1.06	InChI=1S/C5H9Cl2N3O2/c6-1-3-8-5(11)10(9-12)4-2-7/h1-4H2,(H,8,11)
InChIKey	InChI	1.06	DLGOEMSEDOSKAD-UHFFFAOYSA-N

Drug Info: DrugBank

DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License

DrugBank ID	DB00262
Name	Carmustine
Groups	investigational approved
Description	A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed)
Synonyms	Bischloroethyl nitrosourea bis-chloroethylnitrosourea Carmustina Bis(chloroethyl) nitrosourea Carmustine BCNU Carmustinum N,N'-Bis(2-chloroethyl)-N-nitrosourea
Brand Names	BiCNU Gliadel Carmustine for Injection USP Gliadel Wafer Carmustine Obvius Carmustine Bicnu
Indication	For the treatment of brain tumors, multiple myeloma, Hodgkin's disease and Non-Hodgkin's lymphomas.
Categories	Alkylating Activity Alkylating Drugs Amides Antineoplastic Agents Antineoplastic Agents, Alkylating Antineoplastic and Immunomodulating Agents Cardiotoxic antineoplastic agents Cytochrome P-450 CYP1A2 Substrates Cytochrome P-450 Substrates Drugs that are Mainly Renally Excreted Immunosuppressive Agents Myelosuppressive Agents Narrow Therapeutic Index Drugs Nitroso Compounds Nitrosourea Compounds Nitrosoureas Noxae Toxic Actions
ATC-Code	L01AD01
CAS number	154-93-8

Drug Targets

DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License

Name	Target Sequence	Pharmacological Action	Actions
RNA	-	unknown	cross-linking/alkylation
Glutathione reductase, mitochondrial	MALLPRALSAGAGPSWRRAARAFRGFLLLLPEPAALTRALSRAMACRQEP...	unknown	allosteric modulator
DNA	-	unknown	cross-linking/alkylation

Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682